carbamates has been researched along with glycoprotein e2, hepatitis c virus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boson, B; Chamot, C; Cosset, FL; Denolly, S; Dreux, M; Turlure, F | 1 |
1 other study(ies) available for carbamates and glycoprotein e2, hepatitis c virus
| Article | Year |
|---|---|
Daclatasvir Prevents Hepatitis C Virus Infectivity by Blocking Transfer of the Viral Genome to Assembly Sites.
Topics: Antiviral Agents; Carbamates; Cell Line, Tumor; Genome, Viral; Hepacivirus; Humans; Imidazoles; Protein Transport; Pyrrolidines; RNA Transport; RNA, Viral; Valine; Viral Core Proteins; Viral Envelope Proteins; Viral Nonstructural Proteins; Virus Assembly | 2017 |